DR
Dolev Rafaeli
Chief Executive Officer

Dolev Rafaeli insider trades: STRATA Skin Sciences (SSKN) stock buys and sales

Chief Executive Officer, STRATA Skin Sciences Last trade Jul 15, 2024 44 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
34
Open-market trades
since 2012
3
Companies
last trade 2024

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Dolev reports to the SEC

Open-market buys and sales

34 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 15, 2024SSKN↑ Buy$60K
Jan 12, 2016PHMD↓ Sell10b5-1$8K
Jan 8, 2016PHMD↓ Sell10b5-1$29K
Jan 5, 2016PHMD↓ Sell10b5-1$17K
Dec 22, 2015PHMD↓ Sell10b5-1$46K
Nov 18, 2015PHMD↓ Sell10b5-1$7K
Nov 16, 2015PHMD↓ Sell10b5-1$17K
Nov 11, 2015PHMD↓ Sell10b5-1$18K
Nov 6, 2015PHMD↓ Sell10b5-1$8K
Nov 4, 2015PHMD↓ Sell10b5-1$17K
Oct 2, 2015PHMD↓ Sell10b5-1$62K
Sep 22, 2015PHMD↓ Sell10b5-1$23K
Sep 21, 2015PHMD↓ Sell10b5-1$69K
Sep 16, 2015PHMD↓ Sell10b5-1$30K
Apr 1, 2014PHMD↓ Sell10b5-1$274K
Mar 11, 2014PHMD↓ Sell10b5-1$1.9M
Mar 4, 2014PHMD↓ Sell10b5-1$1.4M
Feb 14, 2014PHMD↓ Sell10b5-1$957K
Feb 12, 2014PHMD↓ Sell10b5-1$441K
Jan 14, 2014PHMD↓ Sell10b5-1$1.5M
Sep 3, 2013PHMD↓ Sell10b5-1$995K
Aug 21, 2013PHMD↓ Sell10b5-1$264K
Aug 8, 2013PHMD↓ Sell10b5-1$837K
Aug 5, 2013PHMD↓ Sell10b5-1$651K
Jul 31, 2013PHMD↓ Sell10b5-1$414K
Jul 25, 2013PHMD↓ Sell$1.3M
Jul 1, 2013PHMD↓ Sell$1.7M
Jun 21, 2013PHMD↓ Sell$1.8M
Mar 13, 2013PHMD↓ Sell$2.1M
Mar 5, 2013PHMD↓ Sell$8.4M
Feb 7, 2013PHMD↓ Sell$817K
Jan 15, 2013PHMD↓ Sell$2.6M
Jan 10, 2013PHMD↓ Sell$12K
Oct 9, 2012PHMD↓ Sell$345K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other SSKN insiders

Open-market trades in the last 12 months

About Dolev Rafaeli's insider trades

Dolev Rafaeli is Chief Executive Officer at STRATA Skin Sciences (SSKN). Since Oct 9, 2012, Dolev has reported 1 open-market purchase worth $60K and 33 sales worth $29.0M on SEC Form 4. There have been no open-market trades in the last 12 months.

24 sales (34% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include grants and awards (7 filings), other transactions (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SSKN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.